Skip to main content
ATHE logo
ATHE
(NASDAQ)
Alterity Therapeutics Limited
$3.56-- (--)
Loading... - Market loading

Alterity Therapeutics (ATHE) Stock Price & Financial Analysis

Alterity Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$3.49 - $3.61
52-Week High$7.00
52-Week Low$2.52
Open$3.51
Volume2.87K
Average Volume (3M)2.87K
Market Cap60.32M
Shares Outstanding16.97M
Price to Sales (P/S)11.87
Price to Book (P/B)1.65
EV/EBITDA-0.97
Revenue (TTM)5.21M
Net Income (TTM)-23.58M
Free Cash Flow (TTM)-27.28M
EPS (TTM)$-1.39
Profit Margin-452.58%
Operating Margin-534.24%
Return on Equity (ROE)-63.09%
Debt to Equity0.00
50-Day MA$3.41
200-Day MA$4.03
52-Week Change14.34%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Alterity Therapeutics

What is the current stock price for ATHE?

As of the latest trading session, ATHE stock trades at $3.56. The 52-week range is $2.52–$7.00, with a day range of $3.49–$3.61.

What is the P/E ratio for ATHE?

The P/E ratio (Price-to-Earnings) for ATHE is shown in the Key Statistics section. This valuation metric helps compare Alterity Therapeutics Limited to industry peers.

Does ATHE pay dividends?

Alterity Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ATHE?

Analyst ratings and recommendations for ATHE are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of ATHE?

Alterity Therapeutics's market capitalization is $60.3M, classifying it as a micro-cap company. Alterity Therapeutics operates in the Healthcare sector within the Biotechnology industry.